Blog
RSS FeedPosted by Michael Wonder on 31 Jan 2018
`Life-changing´ breast cancer drug can be routinely used in NHS, says NICE
31 January 2018 - A “life-changing” drug for breast cancer patients has been given the final go-ahead for routine NHS ...
Posted by Michael Wonder on 31 Jan 2018
More Government tax incentives for health insurance?
30 January 2018 - While in the real world consumers struggle to meet private health care costs, health funds are ...
Posted by Michael Wonder on 31 Jan 2018
Health policy reform not helped by Bill Shorten
31 January 2018 - It is noteworthy that shares in Medibank Private hit a record high the day after Opposition ...
Posted by Michael Wonder on 31 Jan 2018
CDF to save NHS £140m over five years
31 January 2018 - At least £140 million is expected to be released into the NHS over the next five ...
Posted by Michael Wonder on 30 Jan 2018
Indicative 1 April 2018 prices - 2018 April cycle
30 January 2018 - Indicative 1 April 2018 prices resulting from the 2018 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 30 Jan 2018
To avoid open bidding, generic-drug makers cut prices outside Quebec
30 January 2018 - The provinces outside Quebec are expecting to save as much as $3-billion over five years after ...
Posted by Michael Wonder on 30 Jan 2018
Post-market review of chronic obstructive pulmonary disease medicines – final report released
30 January 2018 - The final report and outcomes of the post-market review of chronic obstructive pulmonary disease medicines is now ...
Posted by Michael Wonder on 29 Jan 2018
A joint statement from the pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association
29 January 2018 - On behalf of participating federal, provincial, and territorial public drug plans, the pan-Canadian Pharmaceutical Alliance (pCPA), with ...
Posted by Michael Wonder on 29 Jan 2018
Doctors are cleared to prescribe cheaper drug for wet AMD
24 January 2018 - Doctors who prescribe bevacizumab (Avastin) for age related macular degeneration (AMD) will “not raise fitness to ...
Posted by Michael Wonder on 29 Jan 2018
Rare disease medicine changes offer clarity
29 January 2018 - Proposed changes to the provision of medicines for rare diseases should bring greater certainty for people ...
Posted by Michael Wonder on 29 Jan 2018
Medicines Australia welcomes LSDP review outcomes
28 January 2018 - Medicines Australia welcomes the Government’s announcement of an outcome from the post-market review of the Life ...
Posted by Michael Wonder on 29 Jan 2018
Agenda for 31 January TC meeting
29 January 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 28 Jan 2018
Review of the Life Saving Drugs Program - final report and Government response
28 January 2018 - After nearly 4 years and 3 health ministers, the final report and Government's response to the ...
Posted by Michael Wonder on 28 Jan 2018
Is “end of life” a special case? Connecting Q with survey methods to measure societal support for views on the value of life-extending treatments
19 January 2018 - Preference elicitation studies reporting societal views on the relative value of end-of-life treatments have produced equivocal results. ...
Posted by Michael Wonder on 26 Jan 2018
Lowest private health insurance premium change in 17 years
25 January 2018 - The Australian Government’s reforms to take the pressure off private health insurance has today delivered the lowest ...